From Anaheim, Calif., at a meeting of the American Association for Cancer Research
Cholesterol-lowering drugs, especially when combined with anti-inflammatory medication, may inhibit some cancers, two studies suggest.
Tapping into a database that tracks the health of more than 51,000 middle-aged and elderly men, researchers identified 2,074 who developed prostate cancer between 1990 and 2000. In 283 of the men, the cancer was lethal or potentially so, having spread to lymph nodes or other organs.
When analyzing data provided by the participants, Elizabeth Platz of Johns Hopkins Medical Institutions in Baltimore and her colleagues at Harvard University found that men who had been taking cholesterol-lowering drugs were only half as likely to develop potentially lethal prostate cancer as were men not taking such medications. The researchers observed that there was no difference in use of cholesterol drugs between healthy men and those with cancer that was co